These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Why Was the Primary Outcome Switched in a Patient Empowerment Trial? Gray R; Brown E J Perianesth Nurs; 2022 Apr; 37(2):e1. PubMed ID: 35422275 [No Abstract] [Full Text] [Related]
43. Reverse Lasagna's law: the ethics and undesirable consequences of overbooking patients for trials. van den Hoek TC; Ferrari MD Eur J Neurol; 2023 Dec; 30(12):3633-3634. PubMed ID: 37724989 [No Abstract] [Full Text] [Related]
44. [Not Available]. Schilling I; Ehrmann U; Jilani H; Rathjen KI; Gerhardus A Z Evid Fortbild Qual Gesundhwes; 2020 Sep; 155():54-55. PubMed ID: 32863162 [No Abstract] [Full Text] [Related]
45. We Must Act Now:: Building Trust and Increasing Minority Participation in COVID-19 Clinical Trials. Lee M Dela J Public Health; 2020 Nov; 6(5):34-35. PubMed ID: 34467163 [No Abstract] [Full Text] [Related]
46. Disparities based on sex in clinical trials. Ena J Rev Clin Esp (Barc); 2024 Feb; 224(2):114-116. PubMed ID: 38228269 [No Abstract] [Full Text] [Related]
47. Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice. Bramlage P; Fronk EM; Wolf WP; Smolnik R; Sutton G; Schmieder RE Vasc Health Risk Manag; 2015; 11():1-8. PubMed ID: 25565857 [TBL] [Abstract][Full Text] [Related]
48. Effectiveness and cost-effectiveness of a group-based pain self-management intervention for patients undergoing total hip replacement: feasibility study for a randomized controlled trial. Wylde V; Marques E; Artz N; Blom A; Gooberman-Hill R Trials; 2014 May; 15():176. PubMed ID: 24885915 [TBL] [Abstract][Full Text] [Related]
49. Northern Territory Heart Failure Initiative-Clinical Audit (NTHFI-CA)-a prospective database on the quality of care and outcomes for acute decompensated heart failure admission in the Northern Territory: study design and rationale. Iyngkaran P; Tinsley J; Smith D; Haste M; Nadarajan K; Ilton M; Battersby M; Stewart S; Brown A BMJ Open; 2014 Jan; 4(1):e004137. PubMed ID: 24477314 [TBL] [Abstract][Full Text] [Related]
50. Outcomes research and epidemiology: the synergy between public health and clinical practice. Roger VL Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):257-9. PubMed ID: 21586721 [No Abstract] [Full Text] [Related]
51. Participation in cancer trials: recruitment of underserved populations. Paskett ED; Katz ML; DeGraffinreid CR; Tatum CM Clin Adv Hematol Oncol; 2003 Oct; 1(10):607-13. PubMed ID: 16258457 [TBL] [Abstract][Full Text] [Related]
52. The process of clinical trials: a model for successful clinical trial participation. Lengacher CA; Gonzalez LL; Giuliano R; Bennett MP; Cox CE; Reintgen DS Oncol Nurs Forum; 2001 Aug; 28(7):1115-20. PubMed ID: 11517845 [TBL] [Abstract][Full Text] [Related]
53. Clinical trial participation: are we studying the patients we are trying to treat? Wang OJ; Krumholz HM Eur J Heart Fail; 2009 Nov; 11(11):1021-2. PubMed ID: 19875402 [No Abstract] [Full Text] [Related]
54. Minority recruitment and participation in health research. Corbie-Smith GM N C Med J; 2004; 65(6):385-7. PubMed ID: 15714732 [No Abstract] [Full Text] [Related]
55. Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials. Ding EL; Powe NR; Manson JE; Sherber NS; Braunstein JB Arch Intern Med; 2007 May; 167(9):905-12. PubMed ID: 17502531 [TBL] [Abstract][Full Text] [Related]
56. Identifying motivations and barriers to patient participation in clinical trials. Jones JM; Nyhof-Young J; Moric J; Friedman A; Wells W; Catton P J Cancer Educ; 2006; 21(4):237-42. PubMed ID: 17542716 [TBL] [Abstract][Full Text] [Related]